On May 7, Gelonghui | Tailin Biotech (300813.SZ) said on the investor interactive platform that the company currently has no direct layout in the direction of synthetic biology.
泰林生物(300813.SZ)：目前还没有直接在合成生物方向有所布局
Tailin Biology (300813.SZ): Currently, there is no direct layout in the direction of synthetic biology
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.